News / Despite some positive trends in air cargo, it will be an ‘unpredictable’ fourth quarter

first_img New data which reveals weekly trends in air cargo has shown an “unpredictable” start to the fourth quarter. But there are some “grains of hope” according to Peter Stallion of Freight Investor Services.  “China to Europe pricing gives the market a grain of hope that rates are on their way up into the traditional Q4 pricing hike. However trans-pacific rates remain flat or negative,” he added. There are also some positive trends between the US and Europe. While the US Labour Day on 2 September led to a significant volume decline of nearly 20% from the US to Europe, it bounced back the following week, increasing 15%, according to one analyst. In the other direction, Europe to the US, there has been an upward trend in volumes for three consecutive weeks, with last week 10% higher than three weeks previous.  However, warned the analyst, volumes last week, week 37, were still 5% below week 32 volumes. “But at least there has been a positive trend for the last few weeks,” he told The Loadstar. Mr Stallion warned that the softness in the air cargo market this year would cause problems in the fourth quarter for anyone locked into pre-negotiated rates. “For those locked into a slack/peak BSA pricing system, the profitability and commercial sense of the rates that would have been negotiated in Q1 have begun to erode. All the while rates for freight contracts in emerging markets in South East Asia remain highly uncertain.”  And there is of course increased uncertainty now, owing to the volatility of oil prices following the Saudi drone strike.  “Thrown into the mix this week, [is] the unpredictable effect of fuel pricing increases on costs passed through into carrier’s fuel surcharges and base airfreight rates,” said Mr Stallion. “Given the violence of this increase, with Brent Crude Oil, a key benchmark for jet fuel hedging climbing as much as 20% in a few minutes on Monday, the pass-over into linked markets (air, container freight) is somewhat inevitable.” The data for jet fuel prices after the strike in Saudi Arabia is not yet available, but analysts are predicting at least a short-term spike. Analysts said “oil prices had fallen after an initial surge as there seem to be significant volumes of oil in Saudi storage which should help keep exports flowing and mitigate any disruption in the short term,” noted S&P Global Platts Analytics. “But prices are likely to stay supported as the geopolitical risk premium has come back into focus due to the latest attacks.” It added that “prices are likely to break out of the $55-$65/b options range, more likely testing the high of $70/b” previously forecast, if not higher. Mr Stallion said higher jet fuel prices would “cause problems for the ever–popular ACMI dry leases currently flying rotations across the Pacific, damaging margins and cashflow”. © Artur Szczybylo By Alex Lennane 18/09/2019last_img read more

Read More

US debuts life sciences dual-use research policy

first_imgMar 29, 2012 (CIDRAP News) – Federal health officials today unveiled a new policy for overseeing life sciences dual-use research, such as two recent H5N1 transmission studies that have sparked bioterror concerns as well as cries of censorship.The launch of the new policy, first reported by ScienceInsider, comes while a US biosecurity advisory group is meeting to discuss the latest version of two H5N1 transmission papers, one by a group from Erasmus University in the Netherlands and one by a team from the University of Wisconsin, Madison.The move also follows a demand from a US congressman that President Obama’s science office explain why the National Science Advisory Board for Biosecurity (NSABB) didn’t consider the dual-use implications until after the studies were completed and what safeguards are in place to protect Americans against biological attacks. The congressman, Rep Jim Sensenbrenner, R-Wisc., asked John Holdren, who leads the White House Office of Science and Technology Policy, to report back by Mar 31.The NSABB is meeting today and tomorrow to weigh further data presented by the two research groups on their studies.The 4-page policy, which came from the National Institutes of Health (NIH) Office of Biotechnology Activities, requires federal agencies to routinely review potential risks of federally funded studies that involve 15 “high consequence” pathogens and toxins, including H5N1 avian flu, Bacillus anthracis, and Ebola virus.According to the NIH’s Web site, “The fundamental aim of this oversight is to preserve the benefits of life sciences research while minimizing the risk of misuse of the knowledge, information, products, or technologies provided by such research.”The policy expands reviews that the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), the government’s two largest biomedical agencies, already conduct on staff-run studies and extends oversight to federally funded studies at universities and other facilities. The new requirements also apply to other federal agencies that conduct unclassified life sciences research, such as the Department of Defense.It applies to research studies that are on the horizon and ones that have already been funded. Reviews that find dual-use potential require the funding agencies and scientists to develop a risk mitigation plan.According to the new policy, if the risks can’t be mitigated with several suggested measures, federal agencies are required to determine whether to request voluntary redaction of the resulting research publications or communications, to classify the research, or to withhold or terminate funding for the study.Actions to restrict publication may have implications for export control laws and regulations, the new policy states. Earlier this month, the Dutch government said it was considering using export controls to prevent full publication by the Erasmus group.Within 60 days federal agencies are required to report to the White House the number of proposed or ongoing studies related to the 15 high-consequence agents, and in 90 days to report how many have dual-use potential.The NIH has already completed its own dual-use biosecurity assessment and found fewer than 10 studies that warrant further risk management, the Washington Post reported today.See also:Mar 29 ScienceInsider storyUS government dual-use oversight policyNIH Web site on dual useMar 12 CIDRAP News story “Dutch export rules could block publication of Fouchier H5N1 study”Mar 5 CIDRAP News story “Details of H5N1 study sparks queries from congressman, experts”last_img read more

Read More

Nationals Lineup: 5/4/19

first_imgCarter Kieboom SS The Washington Nationals face the Philadelphia Phillies at Citizens Bank Park for their thirty second game of the regular season. Matt Adams 1B Adam Eaton RF With a 13-18 record, the Nats’ send staff ace Patrick Corbin to the mound for his fourth start of the season. Philadelphia gives the ball to right hander, Jake Arrieta. The Phillies come into the game with a 18-13 record. Yan Gomes C Michael A. Taylor CF Andrew Stevenson LF Here is the lineup for the Nationals! Patrick Corbin P Brian Dozier 2B Please follow and like us: Howie Kendrick 3Blast_img read more

Read More